NCT00502242 - Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus | Biotech Hunter

Enrollment

229

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Kidney Transplant

Interventions

DRUG

ramipril

Capsule - initial treatment is 5 mg (active)- oral - once per day

DRUG

ramipril

Capsule - initial treatment is 5 mg (placebo) - oral - once per day

Trial Locations (49)

1181

Pfizer Investigational Site, Buenos Aires

1425

Pfizer Investigational Site, Capital Federal

2193

Pfizer Investigational Site, Johannesburg

4020

Pfizer Investigational Site, Linz

4029

Pfizer Investigational Site, Brisbane

5000

Pfizer Investigational Site, North Terrace

5016

Pfizer Investigational Site, Córdoba

6720

Pfizer Investigational Site, Szeged

7925

Pfizer Investigational Site, Cape Town

8001

Pfizer Investigational Site, Cape Town

10595

Pfizer Investigational Site, Valhalla

14000

Pfizer Investigational Site, Mexico City

14215

Pfizer Investigational Site, Buffalo

17104

Pfizer Investigational Site, Harrisburg

19102

Pfizer Investigational Site, Philadelphia

19107

Pfizer Investigational Site, Philadelphia

32610

Pfizer Investigational Site, Gainesville

44106

Pfizer Investigational Site, Cleveland

44195

Pfizer Investigational Site, Cleveland

48236

Pfizer Investigational Site, Gosse Pointe

49100

Pfizer Investigational Site, Petah Tikva

52242

Pfizer Investigational Site, Iowa City

60637

Pfizer Investigational Site, Chicago

80045

Pfizer Investigational Site, Aurora

80218

Pfizer Investigational Site, Denver

90033

Pfizer Investigational Site, Los Angeles

91054

Pfizer Investigational Site, Erlangen

91700

Pfizer Investigational Site, Veracruz

94115

Pfizer Investigational Site, San Francisco

90033-4612

Pfizer Investigational Site, Los Angeles

40536-0293

Pfizer Investigational Site, Lexington

04102

Pfizer Investigational Site, Portland

02215

Pfizer Investigational Site, Boston

01107

Pfizer Investigational Site, Springfield

01199

Pfizer Investigational Site, Springfield

19102-1192

Pfizer Investigational Site, Philadelphia

02903

Pfizer Investigational Site, Providence

29425-6290

Pfizer Investigational Site, Charleston

1650 CP

Pfizer Investigational Site, San Martín

SA 5011

Pfizer Investigational Site, Woodville South

21041-030

Pfizer Investigational Site, Rio de Janeiro

90020-090

Pfizer Investigational Site, Porto Alegre

90035-074

Pfizer Investigational Site, Porto Alegre

01323-001

Pfizer Investigational Site, São Paulo

01323-030

Pfizer Investigational Site, São Paulo

04038-002

Pfizer Investigational Site, São Paulo

04039-033

Pfizer Investigational Site, São Paulo

H2L 4M1

Pfizer Investigational Site, Montreal

70-111

Pfizer Investigational Site, Szczecin